Unjha Formulations Q1FY27: Profit Back, Costs Down

Key takeaway from Q1FY27

Unjha Formulations Limited returned to profitability in Q1FY27, reporting a net profit of ₹15.69 lakh for the quarter ended June 30, 2026. The turnaround comes after the company reported a net loss of ₹74.28 lakh in Q4FY26. Revenue for Q1FY27 was reported as stable at ₹330.75 lakh. The improvement in the bottom line was supported by a decline in total expenses to ₹314.98 lakh. The company attributed the lower expense base to reduced employee benefits and favourable inventory adjustments. The unaudited financial results were approved by the Board of Directors on August 3, 2026.

Q1FY27 numbers: profit returns, revenue steady

The company’s Q1FY27 performance shows a clear improvement in profitability without a material change in topline. Revenue was stated at ₹330.75 lakh for the quarter. Total expenses were reported at ₹314.98 lakh, creating room for the company to report a net profit of ₹15.69 lakh. The article data specifically points to employee benefit costs easing and inventory adjustments moving in the company’s favour during the quarter. While the report does not provide line-by-line cost items, it indicates that these two factors were central to the quarter’s swing. The return to profit is notable because it follows a loss-making March quarter. For investors, the quarter signals that cost discipline and working-capital related movements can materially change reported profitability at this scale.

Comparison with Q4FY26: what changed

The contrast with Q4FY26 is sharp, as Q4FY26 recorded a net loss of ₹74.28 lakh. In Q1FY27, the company moved back into the black despite revenue being described as stable. The cited driver was a fall in expenses to ₹314.98 lakh, which supported the profit outcome. Inventory adjustments can be volatile from quarter to quarter, and the article notes that these were favourable in Q1FY27. The employee benefits component was also highlighted as lower, suggesting a reduction in staff-related costs or timing differences in recognition. The report does not specify whether the Q4FY26 loss was driven by one-off costs, but it is clear that the Q1FY27 outcome was materially better on expenses.

Board approval and regulatory compliance

Unjha Formulations’ Board approved the unaudited financial results on August 3, 2026. The results were reviewed by the statutory auditors, M/s Jain & Golechha, Chartered Accountants, under Standard on Review Engagement (SRE) 2410. The limited review report stated that nothing came to the auditors’ attention to suggest the financial statements contained material misstatements. The filing was also stated to be compliant with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. For listed companies, this combination of board approval, audit committee review process, and a limited review under SRE 2410 is a standard framework for quarterly reporting. The outcome, as described, indicates procedural compliance and a clean limited review conclusion.

Investor actions: AGM e-voting schedule and cut-off

Alongside financial reporting, Unjha Formulations set key dates for shareholder voting. The company fixed August 7, 2026 as the cut-off date for determining e-voting eligibility for its 32nd AGM. E-voting is scheduled to take place from August 11 to August 13 through CDSL. The entitlement for voting is strictly based on holdings as of the cut-off date. For shareholders and brokers, these timelines matter because the eligibility for voting does not change after the cut-off, even if shares are bought or sold later. The article does not mention AGM agenda items, but it establishes the timeline and eligibility rules.

Stock and valuation data mentioned in the report

The article text includes market data points that investors may use as reference. It states a share price of ₹20.85 with a change of -₹0.10 (-0.48%) and notes this as a BSE print (timestamp shown as 28 Apr, 4:00 PM). It also mentions a separate reference point: as of 23 Jun 2026, Unjha Formulations share price is ₹19.9. Market capitalisation was cited as ₹9.3418425 crore, calculated based on the latest share price mentioned in that section. These price points are presented as snapshots rather than a continuous series, and the article does not link them directly to the Q1FY27 announcement.

FY26 audited context: full-year improvement, weak Q4

The broader context in the article includes FY26 audited results. For the year ended March 31, 2026, the company reported audited net profit of ₹70.47 lakh, up from ₹40.76 lakh in FY25. Total income from operations for FY26 was reported at ₹1,574.87 lakh versus ₹1,397.68 lakh in FY25. The same FY26 coverage also highlights that Q4FY26 recorded a net loss of ₹74.28 lakh. Balance sheet metrics were also cited: total assets of ₹551.04 lakh and cash and cash equivalents of ₹164.48 lakh. The board meeting to approve audited standalone results for the quarter and year ended March 31, 2026 was referenced as being held on May 18, 2026, with disclosures also stating that year-end performance was made public on May 19, 2026 via newspaper advertisements.

Key figures at a glance

Timeline: approvals, voting dates, disclosures

Market impact: what the numbers suggest

The Q1FY27 update is primarily a financial reporting event, and the article provides only limited trading context. The cited share price snapshot of ₹20.85 shows a marginal decline of 0.48% for the referenced session. The market capitalisation was cited at ₹9.3418425 crore based on the latest share price used in that section. For a company of this size, quarter-to-quarter swings in costs and inventory adjustments can have an outsized impact on reported profits, and that is reflected in the move from a ₹74.28 lakh loss in Q4FY26 to a ₹15.69 lakh profit in Q1FY27. The article does not provide guidance, order book details, or segment information, so the market read-through remains anchored to the reported profitability and compliance process.

Conclusion

Unjha Formulations’ Q1FY27 results show a return to profitability, supported by lower expenses while revenue remained around ₹330.75 lakh. The board approved the unaudited results on August 3, 2026, following a limited review under SRE 2410 that reported no material misstatements. Shareholders also have a defined AGM e-voting timeline, with August 7, 2026 as the cut-off date and voting scheduled from August 11 to 13 via CDSL. The next set of updates investors typically track will be subsequent quarterly filings and AGM outcomes as disclosed to the exchanges.